carvacrol has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi, M; Ahmadvand, H; Eidi, A; Khaksarian, M; Sotoodehnejadnematalahi, F | 1 |
| Amiri, H; Ayoobi, F; Ghavamabadi, RT; Jafarzadeh, A; Mahmoodi, M; Rahmani, M; Sankian, M; Taghipour, Z | 1 |
2 other study(ies) available for carvacrol and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Effect of Carvacrol on histological analysis and expression of genes involved in an animal model of multiple sclerosis.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Interleukin-1; Interleukin-17; Mice; Mice, Inbred C57BL; Multiple Sclerosis; NF-kappa B; Rats; Rats, Inbred Lew; Spinal Cord; Tumor Necrosis Factor-alpha | 2023 |
Carvacrol ameliorates experimental autoimmune encephalomyelitis through modulating pro- and anti-inflammatory cytokines.
Topics: Animals; Anti-Inflammatory Agents; Cymenes; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Interferon-gamma; Interleukin-10; Interleukin-17; Interleukin-4; Interleukin-6; Mice; Mice, Inbred C57BL; Monoterpenes; Spinal Cord; Transforming Growth Factor beta | 2019 |